Mammalian target of rapamycin inhibition and alloantigen-specific regulatory T cells synergize to promote long-term graft survival in immunocompetent recipients

Giorgio Raimondi*, Tina L. Sumpter, Benjamin M. Matta, Mahesh Pillai, Natasha Corbitt, Yoram Vodovotz, Zhiliang Wang, Angus W. Thomson

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

85 Scopus citations

Fingerprint

Dive into the research topics of 'Mammalian target of rapamycin inhibition and alloantigen-specific regulatory T cells synergize to promote long-term graft survival in immunocompetent recipients'. Together they form a unique fingerprint.

Medicine & Life Sciences